Fundz

Cojourney Inc. Secures $30 Million Financing And Announces Expansion Of Us Operations: High Quality, Cost Effective, Commercial Scale Manufacturing Platform For Cell And Gene Therapies

PRIVATEJul 13, 2023

Amount Raised

$30 Million

Round Type

Funding Round

PhiladelphiaManufacturingBiotechnology

Investors

Lake Bleu CapitalLegend Star Investment ManagementGL VenturesLegend Capital

Description

CoJourney Inc. a global innovator in manufacturing and development of cell and gene therapies is pleased to announce completion of a $30 M Series A financing and expansion of its US organization and commercial manufacturing capabilities. This funding round was led by Legend Capital and supported by GL Ventures, Legend Star Investment Management and Lake Bleu Capital.

Quick answer

CoJourney raised $30 Million in a Funding Round round, dated July 13, 2023. Investors: Lake Bleu Capital, Legend Star Investment Management, GL Ventures and Legend Capital. CoJourney is based in Philadelphia, Pennsylvania, United States.

How much did CoJourney raise?
CoJourney raised $30 Million in a Funding Round round on July 13, 2023.
Who invested in CoJourney?
Lake Bleu Capital, Legend Star Investment Management, GL Ventures and Legend Capital are named as investors in this round.
What does CoJourney do?
CoJourney CO. is reimagining cell and gene therapy CDMO services globally.
Where is CoJourney based and how big is it?
CoJourney is based in Philadelphia, Pennsylvania, United States.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as CoJourney that raised within 45 days of this round, from Fundz verified event records.

  • Nature's Toolbox raised $10M on August 25, 2023.
  • Cellares raised $255M (Series C) on August 23, 2023.
  • Advanced NanoTherapies raised $4M (Seed) on August 22, 2023.
  • Ecovia Renewables raised $510K (Seed) on August 15, 2023.
  • Boston Micro Fabrication raised $24M (Series D) on August 10, 2023.
  • Persist AI raised $4M (Seed) on August 4, 2023.

Who to call at CoJourney, and when

A new round usually means CoJourney is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CoJourney raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CoJourney, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CoJourney. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CoJourney

Location

Philadelphia, Pennsylvania, United States

About

CoJourney CO. is reimagining cell and gene therapy CDMO services globally. Our platform is built on High Purity, High Yield, On Time Supply and Significantly Reduced Costs. We provide process development and clinical and commercial mfg. through a range of platform technologies, including: (1) Plasmids, (2) mRNA, (3) AAV / adenovirus, (4) Lentivirus, (5) Retrovirus, (6) Custom Viral Vectors. We have proprietary high-purity, high-yield, streamlined and cost-effective processes and our facilities are compliant under US FDA, EU EMA and China NMPA Plasmid, mRNA, and Viral Vector development, manufacturing and import/export regulations. Plasmids are manufactured in a multi-product cGMP facility that includes multiple upstream suites, downstream suites and a fill-finish suite with an isolator and filler. The facility includes 30L disposable fermenters for plasmid production. Viral Vectors are manufactured in a cGMP viral vector facility that includes multiple upstream cell culture, upstream viral vector production suites, downstream processing and fill-finish suites. The facility includes 500L and 2,000L disposable bioreactors for viral vector production. CoJourney’s Process Development labs allow separate, client specific project rooms and are equipped with state of the art and large-scale equipment. The analytical development and Quality Control laboratories provide state of the art analytical equipment are focused on analytical development and performing all stages of release testing for plasmids and viral vectors. CoJourney is currently manufacturing AAV-based gene therapies that have been approved for use in global clinical trials: 1) rAAV based gene therapy for Neurovascular Age-Related Macular Degeneration (wet AMD) in USA 2) AAV based gene therapy for Spinal Muscular Atrophy (SMA) in China Please contact us to discuss how our innovative approaches and timely, cost-effective solutions can address your needs. Please contact us for more information.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CoJourney raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for CoJourney's next move

See what Strategic adds

CoJourney raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.